These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 22922317

  • 1. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Tan H, Zhao J, Wang S, Zhang L, Wang H, Huang B, Liang Y, Yu X, Yang N.
    Int Immunopharmacol; 2012 Dec; 14(4):401-9. PubMed ID: 22922317
    [Abstract] [Full Text] [Related]

  • 2. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M, Taniguchi H, Koya D, Kanasaki K, Sho R, Kato Y, Kojima R, Haneda M, Inomata N.
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [Abstract] [Full Text] [Related]

  • 3. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.
    Liao TD, Nakagawa P, Janic B, D'Ambrosio M, Worou ME, Peterson EL, Rhaleb NE, Yang XP, Carretero OA.
    Am J Physiol Renal Physiol; 2015 May 15; 308(10):F1146-54. PubMed ID: 25740596
    [Abstract] [Full Text] [Related]

  • 4. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis.
    Sun Y, Yang F, Yan J, Li Q, Wei Z, Feng H, Wang R, Zhang L, Zhang X.
    Life Sci; 2010 Aug 14; 87(7-8):232-9. PubMed ID: 20624403
    [Abstract] [Full Text] [Related]

  • 5. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
    Zhao J, Zhang H, Huang Y, Wang H, Wang S, Zhao C, Liang Y, Yang N.
    Int Immunopharmacol; 2013 Sep 14; 17(1):116-22. PubMed ID: 23770281
    [Abstract] [Full Text] [Related]

  • 6. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
    Hu Q, Yang C, Wang Q, Zeng H, Qin W.
    PLoS One; 2015 Sep 14; 10(7):e0133724. PubMed ID: 26208003
    [Abstract] [Full Text] [Related]

  • 7. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2003 Sep 14; 48(9):2555-66. PubMed ID: 13130475
    [Abstract] [Full Text] [Related]

  • 8. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.
    Wang M, Liu R, Jia X, Mu S, Xie R.
    Int J Mol Med; 2010 Dec 14; 26(6):795-801. PubMed ID: 21042772
    [Abstract] [Full Text] [Related]

  • 9. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B, Ye H, You X, Ni H, Chen X, Li L.
    Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.
    Kidney Int; 2004 Sep 01; 66(3):1018-28. PubMed ID: 15327395
    [Abstract] [Full Text] [Related]

  • 11. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
    Wang S, Yang N, Zhang L, Huang B, Tan H, Liang Y, Li Y, Yu X.
    Lupus; 2010 Sep 01; 19(10):1171-80. PubMed ID: 20501525
    [Abstract] [Full Text] [Related]

  • 12. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
    Li X, Liu J, Zhao Y, Xu N, Lv E, Ci C, Li X.
    BMC Nephrol; 2022 Jul 08; 23(1):243. PubMed ID: 35804318
    [Abstract] [Full Text] [Related]

  • 13. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Nov 08; 54(11):3591-600. PubMed ID: 17075801
    [Abstract] [Full Text] [Related]

  • 14. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
    Shimizu S, Nakashima H, Masutani K, Inoue Y, Miyake K, Akahoshi M, Tanaka Y, Egashira K, Hirakata H, Otsuka T, Harada M.
    Rheumatology (Oxford); 2004 Sep 08; 43(9):1121-8. PubMed ID: 15213333
    [Abstract] [Full Text] [Related]

  • 15. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep 08; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

  • 16. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
    Chan GCW, Wu HJ, Chan KW, Yiu WH, Zou A, Huang XR, Lan HY, Lai KN, Tang SCW.
    Nephrology (Carlton); 2018 Apr 08; 23(4):297-307. PubMed ID: 28075040
    [Abstract] [Full Text] [Related]

  • 17. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 08; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 18. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ, Belemezova E, Eis V, Segerer S, Vielhauer V, Perez de Lema G, Kretzler M, Cohen CD, Frink M, Horuk R, Hudkins KL, Alpers CE, Mampaso F, Schlöndorff D.
    J Am Soc Nephrol; 2004 Jun 08; 15(6):1504-13. PubMed ID: 15153561
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice].
    Ding ZX, Yang SF, Wu QF, Lu Y, Chen YY, Nie XL, Jie HY, Qi JM, Wang FS.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr 08; 31(4):656-60. PubMed ID: 21515463
    [Abstract] [Full Text] [Related]

  • 20. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar 08; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.